GO:0002622 regulation of B cell antigen processing and presentation: Immune Regulation, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0002622 describes any process that modulates the frequency, rate, or extent of B cell antigen processing and presentation, a central step in adaptive immunity.
• B cells process and present antigen via MHC class II to CD4 T cells, and this function is regulated by Fc receptors, cytokines, and checkpoint molecules.
• Antibody feedback regulation through Fc receptors directly controls B cell activation and antigen presentation, linking humoral immunity to antigen presentation efficiency.
• IL-10-producing tolerogenic dendritic cells can regulate antigen-specific B cell responses, showing that the regulation of B cell antigen processing and presentation is influenced by the broader immune microenvironment.
• IRF8 mutations in B cell lymphoma cause CD74-dependent deregulation of antigen processing and MHCII presentation, providing a direct link between this GO term and cancer immune evasion.
• B-cell-specific checkpoint molecules regulate anti-tumour immunity, highlighting the therapeutic potential of targeting regulatory pathways of B cell antigen presentation.
Description
Regulation of B cell antigen processing and presentation (GO:0002622) is a biological process that encompasses any mechanism controlling the frequency, rate, or extent of antigen processing and presentation by B cells. B cells are professional antigen-presenting cells that internalize, process, and display antigenic peptides on MHC class II molecules to CD4 T cells, thereby initiating and shaping adaptive immune responses. The regulation of this process is critical because it determines whether B cells effectively activate T cells or instead promote tolerance or immune evasion. Dysregulation of B cell antigen processing and presentation is implicated in autoimmune diseases, immunodeficiency, and cancer. Understanding the molecular players and regulatory circuits of GO:0002622 is therefore essential for immunology researchers and for the development of targeted immunotherapies.
regulation of B cell antigen processing and presentation At A Glance
| GO ID | GO:0002622 |
|---|---|
| GO term | regulation of B cell antigen processing and presentation |
| Ontology | biological_process |
| Synonym | regulation of B-cell antigen processing and presentation; regulation of B lymphocyte antigen processing and presentation; regulation of B-lymphocyte antigen processing and presentation |
| Major function | Modulates the frequency, rate, or extent of antigen processing and presentation by B cells |
| Related process | B cell activation, antigen presentation via MHC class II, antibody feedback regulation |
| Key regulators | Fc receptors, cytokines (e.g., IL-10), checkpoint molecules, transcription factors such as IRF8 |
| Disease relevance | B cell lymphoma, autoimmunity, immunodeficiency, anti-tumour immunity |
What Is GO:0002622?
GO:0002622, regulation of B cell antigen processing and presentation, is defined as any process that modulates the frequency, rate, or extent of B cell antigen processing and presentation. In other words, it covers all regulatory inputs that control how B cells take up, degrade, and display antigens on MHC molecules to T cells.
Why Is regulation of B cell antigen processing and presentation Important in Cell Biology?
Regulation of B cell antigen processing and presentation is important because it determines the efficiency with which B cells activate CD4 T cells, a step that is essential for adaptive immunity. Fc receptor-mediated antibody feedback directly regulates B cell activation and antigen presentation, thereby tuning the magnitude and quality of immune responses. In cancer, B-cell-specific checkpoint molecules that regulate anti-tumour immunity can influence antigen presentation and shape the tumour microenvironment. Moreover, mutations in IRF8 in B cell lymphoma lead to CD74-dependent deregulation of antigen processing and MHCII presentation, allowing immune evasion. Thus, understanding GO:0002622 has direct implications for vaccine design, autoimmune disease, and cancer immunotherapy.
• Controls the initiation of CD4 T cell responses by regulating how B cells present antigen.
• Fc receptor-mediated antibody feedback modulates B cell antigen presentation, linking innate and adaptive immunity.
• IL-10-producing tolerogenic dendritic cells regulate antigen-specific B cell responses, showing cross-talk between immune cell types.
• B-cell-specific checkpoint molecules regulate anti-tumour immunity, making this process a target for cancer immunotherapy.
• IRF8 mutations in B cell lymphoma cause CD74-dependent deregulation of MHCII antigen processing, promoting immune evasion.
• Anti-CD23 therapies can modulate B cell activation and antigen presentation in allergic and autoimmune conditions.
• B cells can regulate CD8 T cell responses, expanding the impact of B cell antigen presentation beyond CD4 T cells.
• Dysregulation of this process contributes to autoimmunity, immunodeficiency, and lymphoma pathogenesis.
What Happens During regulation of B cell antigen processing and presentation?
Antigen uptake and internalization
In simple terms: B cells grab antigens from their surroundings and pull them inside.
B cells capture antigen through their B cell receptor (BCR) or through Fc receptors, which bind antibody-antigen complexes. This uptake is the first step that can be regulated, as Fc receptor engagement modulates the efficiency of antigen internalization and subsequent presentation. Antibody feedback regulation via Fc receptors directly influences B cell activation and the amount of antigen that enters the processing pathway.
Antigen processing and MHC class II loading
In simple terms: Inside the B cell, the antigen is chopped into pieces and loaded onto MHC class II molecules.
After internalization, antigens are degraded in endosomal compartments, and peptides are loaded onto MHC class II molecules with the help of chaperones such as CD74. This step is subject to regulation; for example, IRF8 mutations in B cell lymphoma lead to CD74-dependent deregulation of antigen processing and presentation in MHCII complexes. The frequency and rate of peptide loading determine how many antigen-MHCII complexes reach the cell surface.
Surface presentation and T cell interaction
In simple terms: The B cell shows the antigen pieces to T cells to trigger an immune response.
Peptide-MHCII complexes are displayed on the B cell surface for recognition by CD4 T cells. The extent of this presentation is regulated by B-cell-specific checkpoint molecules that can modulate anti-tumour immunity. Additionally, B cells can regulate CD8 T cell responses, indicating that B cell antigen presentation influences multiple T cell subsets.
Regulation by cytokines and tolerogenic signals
In simple terms: Other immune cells release signals that tell B cells to dial antigen presentation up or down.
IL-10-producing tolerogenic dendritic cells regulate antigen-specific B cell responses, demonstrating that the cytokine microenvironment controls B cell antigen processing and presentation. Anti-CD23 agents can also modulate B cell activation and antigen presentation, providing a pharmacological handle on this process. These regulatory inputs ensure that B cell antigen presentation is appropriately tuned to the context.
Key Genes Involved in GO:0002622 regulation of B cell antigen processing and presentation
The following genes and proteins are central to the regulation of B cell antigen processing and presentation, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| Fc receptors (e.g., FCGR2B) | Bind antibody-antigen complexes and regulate B cell activation and antigen presentation | Target for antibody feedback regulation studies |
| CD23 (FCER2) | Low-affinity IgE receptor that modulates B cell activation and antigen presentation | Therapeutic target in allergy and autoimmunity |
| IL10 | Cytokine that promotes tolerogenic signals and regulates antigen-specific B cell responses | Studied in tolerogenic dendritic cell-B cell interactions |
| IRF8 | Transcription factor regulating MHCII antigen processing and presentation | Mutations linked to B cell lymphoma immune evasion |
| CD74 | Chaperone for MHC class II; deregulated in IRF8-mutant lymphoma | Key node in CD74-dependent antigen processing defects |
| MHC class II (HLA-DR, etc.) | Present processed peptides to CD4 T cells | Central to antigen presentation assays |
| CD40 | Costimulatory molecule on B cells that enhances antigen presentation | Target for B cell activation studies |
| CD80/CD86 | Costimulatory ligands for T cell activation | Markers of B cell antigen-presenting capacity |
| PD-L1 (CD274) | Checkpoint molecule that can regulate B cell function and anti-tumour immunity | B-cell-specific checkpoint studies |
| IL-10 receptor | Mediates IL-10 signals that regulate B cell responses | Tolerogenic regulation studies |
| BCR (surface immunoglobulin) | Captures antigen for processing and presentation | Antigen uptake studies |
| CD4 | T cell co-receptor that recognizes MHC class II | Readout of B cell antigen presentation |
| CD8 | T cell co-receptor; B cells can regulate CD8 T cell responses | B cell-CD8 T cell interaction studies |
| CD74 (invariant chain) | Protects MHCII and guides peptide loading | CD74-dependent deregulation in lymphoma |
| IRF4 | Transcription factor involved in B cell differentiation and antigen presentation | B cell activation studies |
| BLIMP1 (PRDM1) | Regulates plasma cell differentiation and antigen presentation capacity | B cell fate studies |
| XBP1 | Transcription factor for secretory cell differentiation; affects antigen presentation | B cell differentiation studies |
| AICDA (AID) | Enzyme in antibody diversification; influences B cell antigen presentation | Germinal center studies |
How Is regulation of B cell antigen processing and presentation Regulated?
Regulation of B cell antigen processing and presentation is controlled at multiple levels. Fc receptors, particularly inhibitory FcγRIIB, modulate B cell activation and antigen presentation in response to antibody-antigen complexes, a process known as antibody feedback regulation. Cytokines such as IL-10, produced by tolerogenic dendritic cells, can suppress or alter antigen-specific B cell responses. B-cell-specific checkpoint molecules, including PD-L1 and others, regulate anti-tumour immunity and can impact antigen presentation. Transcription factors like IRF8 control the expression of MHCII pathway components; IRF8 mutations lead to CD74-dependent deregulation of antigen processing. Pharmacological agents such as anti-CD23 antibodies can also modulate B cell activation and antigen presentation.
regulation of B cell antigen processing and presentation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| IRF8 | B cell lymphoma immune evasion via CD74-dependent MHCII deregulation | IRF8-mutant B cell lymphoma cell lines; KO and point-mutation models |
| CD74 | Antigen processing defect in lymphoma | CD74 knockout B cells; knock-in of mutant CD74 |
| FCGR2B | Autoimmunity and antibody feedback dysregulation | Fcgr2b knockout mice; point-mutation models |
| FCER2 (CD23) | Allergy and autoimmune B cell activation | Anti-CD23 treated B cells; CD23 knockout models |
| IL10 | Tolerogenic regulation of B cell responses | IL-10 knockout mice; IL-10 reporter models |
B cell lymphoma and immune evasion
IRF8-mutant B cell lymphoma evades immunity through a CD74-dependent deregulation of antigen processing and presentation in MHCII complexes. This directly links GO:0002622 to cancer immune evasion, as reduced or altered antigen presentation prevents T cell recognition of tumour cells. B-cell-specific checkpoint molecules further regulate anti-tumour immunity, suggesting that therapeutic targeting of these pathways could restore antigen presentation.
Autoimmunity and allergy
Fc receptor-mediated regulation of B cell activation and antigen presentation is critical for preventing autoimmunity. Anti-CD23 therapies are used in allergic and autoimmune conditions, in part by modulating B cell activation and antigen presentation. Dysregulated antibody feedback can lead to excessive B cell antigen presentation and autoantibody production.
Immunodeficiency and vaccine responses
Proper regulation of B cell antigen processing and presentation is required for effective adaptive immunity. Defects in this process can impair T cell activation and antibody responses, leading to immunodeficiency. Tolerogenic dendritic cells that produce IL-10 can suppress antigen-specific B cell responses, which may be relevant in chronic infections or cancer.
From regulation of B cell antigen processing and presentation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does a candidate gene regulate B cell antigen presentation? | Knockout cell line (e.g., CRISPR KO in B lymphoma or primary B cells) |
| Does a specific point mutation in IRF8 alter MHCII presentation? | Point-mutation knock-in cell model |
| Does overexpression of a checkpoint molecule suppress antigen presentation? | Overexpression cell model |
| Where does a protein localize during antigen processing? | Tagged knock-in (e.g., GFP or HA tag) |
| Does a regulatory protein interact with MHCII pathway components? | Knock-in with affinity tag for proteomics |
| Can a drug modulate B cell antigen presentation? | Pharmacological treatment of wild-type and KO B cells |
How to Study the regulation of B cell antigen processing and presentation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Flow cytometry | Surface MHCII and costimulatory molecule levels | Quantify antigen presentation capacity |
| T cell co-culture | T cell activation and proliferation | Functional readout of B cell antigen presentation |
| Immunoprecipitation + mass spectrometry | MHCII-associated peptides and proteins | Identify antigen processing defects |
| CRISPR knockout screening | Genes required for antigen presentation | Discover novel regulators |
| RNA-seq | Transcriptional changes in antigen presentation genes | Assess regulatory effects on gene expression |
| Western blot | Protein levels of MHCII pathway components | Validate knockout or overexpression |
| ELISA | Cytokine production (e.g., IL-10) | Measure tolerogenic signals |
| Confocal microscopy | Subcellular localization of MHCII and CD74 | Study antigen processing compartments |
Flow cytometry and MHCII surface staining
Flow cytometry is used to measure surface MHC class II and costimulatory molecules on B cells, providing a direct readout of antigen presentation capacity. This method can quantify changes in response to regulatory signals such as Fc receptor engagement or cytokine treatment.
Antigen-specific T cell activation assays
Co-culture of B cells with antigen-specific CD4 or CD8 T cells followed by measurement of T cell proliferation or cytokine production assesses the functional outcome of B cell antigen processing and presentation. This is a key method to test regulatory interventions.
Proteomics and immunoprecipitation
Immunoprecipitation of MHCII complexes followed by mass spectrometry can identify peptides and associated proteins, revealing how regulatory factors alter the antigen presentation repertoire. This approach is useful for studying CD74-dependent deregulation.
CRISPR screening and bioinformatics
Genome-wide CRISPR screens can identify genes that regulate B cell antigen processing and presentation, followed by bioinformatics pathway analysis to uncover regulatory networks. Such screens are powerful for discovering novel regulators of GO:0002622.
How CRISPR Can Be Used to Study GO:0002622 regulation of B cell antigen processing and presentation
Knockout
CRISPR knockout of candidate regulatory genes (e.g., IRF8, CD74, FCGR2B) in B cell lines or primary B cells can determine whether they are required for B cell antigen processing and presentation. Knockout models are essential for loss-of-function studies in GO:0002622.
Point Mutation
Point mutations identified in patients (e.g., IRF8 mutations in lymphoma) can be introduced into B cells using CRISPR base editing or homology-directed repair to study their effects on antigen presentation. This approach reveals how specific amino acid changes deregulate MHCII processing.
Knock-in
Knock-in of tagged versions of MHCII or CD74 allows tracking of antigen processing compartments and protein interactions. Tagged knock-in models are valuable for proteomic and imaging studies of GO:0002622.
Overexpression
Overexpression of regulatory molecules such as checkpoint ligands (e.g., PD-L1) or cytokines (e.g., IL-10) can suppress B cell antigen presentation and model tolerogenic or tumour environments. Overexpression models help test gain-of-function hypotheses in GO:0002622.
How EDITGENE Supports regulation of B cell antigen processing and presentation Research
Researchers studying regulation of B cell antigen processing and presentation-related genes often need to determine whether a candidate gene is causally involved in modulating antigen presentation, and to dissect the precise molecular mechanism. EDITGENE provides a comprehensive suite of CRISPR-based cell model services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for regulation of B cell antigen processing and presentation research.
Frequently Asked Questions About regulation of B cell antigen processing and presentation
What is GO:0002622 regulation of B cell antigen processing and presentation?
GO:0002622 is a biological process term describing any mechanism that modulates the frequency, rate, or extent of antigen processing and presentation by B cells.
What genes are involved in regulation of B cell antigen processing and presentation?
Key genes include IRF8, CD74, FCGR2B, FCER2 (CD23), IL10, MHC class II genes, and checkpoint molecules such as PD-L1.
How do Fc receptors regulate B cell antigen presentation?
Fc receptors bind antibody-antigen complexes and modulate B cell activation and antigen presentation, a process known as antibody feedback regulation.
What is the role of IRF8 in B cell antigen processing?
IRF8 regulates MHCII antigen processing; mutations in IRF8 lead to CD74-dependent deregulation of antigen presentation in B cell lymphoma.
How do tolerogenic dendritic cells regulate B cell responses?
IL-10-producing tolerogenic dendritic cells can regulate antigen-specific B cell responses, influencing B cell antigen presentation.
Can B cells regulate CD8 T cell responses?
Yes, B cells can regulate CD8 T cell responses, in addition to their classical role in CD4 T cell activation.
What diseases are linked to dysregulation of B cell antigen presentation?
Dysregulation is linked to B cell lymphoma, autoimmunity, allergy, and immunodeficiency.
How can I study regulation of B cell antigen processing and presentation?
Common methods include flow cytometry, T cell co-culture assays, immunoprecipitation-mass spectrometry, and CRISPR screens.
What CRISPR models are available for this process?
Knockout, point mutation, knock-in, and overexpression models can be generated in B cell lines or primary B cells.
Why is regulation of B cell antigen processing and presentation important for immunotherapy?
B-cell-specific checkpoint molecules regulate anti-tumour immunity, and targeting these pathways can enhance antigen presentation and T cell activation.
Conclusion
Regulation of B cell antigen processing and presentation (GO:0002622) is a critical biological process that controls how B cells initiate and shape adaptive immune responses. Its dysregulation contributes to lymphoma immune evasion, autoimmunity, and immunodeficiency, making it a key area of immunological research. Advances in CRISPR-based cell models and screening technologies now allow precise dissection of the regulatory networks governing this process, offering new opportunities for therapeutic intervention.
References
- 1. Bonilla FA et al.. 2010. Adaptive immunity.. J Allergy Clin Immunol 125(2 Suppl 2):S33-40 PMID: 20061006
- 2. Bod L et al.. 2023. B-cell-specific checkpoint molecules that regulate anti-tumour immunity.. Nature 619(7969):348-356 PMID: 37344597
- 3. Fridman WH. 1993. Regulation of B-cell activation and antigen presentation by Fc receptors.. Curr Opin Immunol 5(3):355-60 PMID: 8347298
- 4. Rosenwasser LJ et al.. 2005. Anti-CD23.. Clin Rev Allergy Immunol 29(1):61-72 PMID: 16222084
- 5. Heyman B. 2024. Antibody feedback regulation.. Immunol Rev 328(1):126-142 PMID: 39180190
- 6. Morali K et al.. 2025. Antigen-specific B cell response regulation by IL-10-producing tolerogenic dendritic cells.. Sci Adv 11(47):eadu3624 PMID: 41270166
- 7. Van Meerhaeghe T et al.. 2023. Regulation of CD8 T cell by B-cells: A narrative review.. Front Immunol 14:1125605 PMID: 36969196
- 8. Qiu Z et al.. 2024. IRF8-mutant B cell lymphoma evades immunity through a CD74-dependent deregulation of antigen processing and presentation in MHCII complexes.. Sci Adv 10(28):eadk2091 PMID: 38996030
